Verve Therapeutics Sets Annual Meeting for June 5
| Field | Detail |
|---|---|
| Company | Verve Therapeutics, Inc. |
| Form Type | DEFA14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting
TL;DR
Verve Therapeutics annual meeting June 5th. Vote your shares!
AI Summary
Verve Therapeutics, Inc. is holding its Annual Meeting of Stockholders on Thursday, June 5, 2025, at 9:00 AM Eastern Time. The company is filing a Definitive Additional Materials (DEFA14A) with the SEC, indicating this is not a preliminary proxy statement. The filing fee was not required.
Why It Matters
This filing provides shareholders with important information regarding the upcoming annual meeting, allowing them to exercise their voting rights on company matters.
Risk Assessment
Risk Level: low — This filing is a standard proxy statement for an annual meeting and does not contain information about significant financial events or strategic shifts.
Key Players & Entities
- Verve Therapeutics, Inc. (company) — Registrant
- June 5, 2025 (date) — Annual Meeting Date
FAQ
What is the date and time of Verve Therapeutics' Annual Meeting of Stockholders?
The Annual Meeting of Stockholders is scheduled for Thursday, June 5, 2025, at 9:00 AM Eastern Time.
What type of SEC filing is this document?
This document is a DEFA14A, specifically marked as Definitive Additional Materials.
Who is the filer of this proxy statement?
The filer is Verve Therapeutics, Inc., the Registrant.
What is the fiscal year end for Verve Therapeutics, Inc.?
The fiscal year end for Verve Therapeutics, Inc. is December 31.
Was a filing fee required for this document?
No fee was required for this filing.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 25, 2025 regarding Verve Therapeutics, Inc..